scholarly article | Q13442814 |
P50 | author | Tingjun Hou | Q51200321 |
Youyong Li | Q37829831 | ||
Huiyong Sun | Q43371037 | ||
P2093 | author name string | Lei Xu | |
Sheng Tian | |||
P2860 | cites work | The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools | Q24248165 |
Comparison of simple potential functions for simulating liquid water | Q26778447 | ||
Compensating enthalpic and entropic changes hinder binding affinity optimization | Q27646075 | ||
Discovery of a Potential Allosteric Ligand Binding Site in CDK2 | Q27666837 | ||
Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK) | Q27671432 | ||
Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors | Q28219491 | ||
The impact of structural genomics: expectations and outcomes | Q28292735 | ||
Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO) | Q29012795 | ||
Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes | Q29397708 | ||
A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations | Q29547632 | ||
Development and testing of a general amber force field | Q29547642 | ||
Automatic atom type and bond type perception in molecular mechanical calculations | Q29616744 | ||
Exploring protein native states and large-scale conformational changes with a modified generalized born model | Q29617088 | ||
Assessing the performance of MM/PBSA and MM/GBSA methods. 3. The impact of force fields and ligand charge models | Q45179427 | ||
Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain | Q46098395 | ||
The implementation of a fast and accurate QM/MM potential method in Amber | Q46159606 | ||
Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance | Q46523471 | ||
Insight into crizotinib resistance mechanisms caused by three mutations in ALK tyrosine kinase using free energy calculation approaches | Q47763550 | ||
Exploring the molecular basis of dsRNA recognition by Mss116p using molecular dynamics simulations and free-energy calculations | Q47911131 | ||
Comparative assessment of scoring functions on a diverse test set. | Q48026800 | ||
Binding affinities of factor Xa inhibitors estimated by thermodynamic integration and MM/GBSA. | Q51590039 | ||
Ligand affinities predicted with the MM/PBSA method: dependence on the simulation method and the force field. | Q51930255 | ||
Influence of hyperthermophilic protein Cren7 on the stability and conformation of DNA: insights from molecular dynamics simulation and free energy analysis. | Q54409858 | ||
Structural and energetic analyses of SNPs in drug targets and implications for drug therapy. | Q54492091 | ||
Understanding the molecular basis of MK2-p38α signaling complex assembly: insights into protein-protein interaction by molecular dynamics and free energy studies. | Q54507909 | ||
Assessing protein kinase selectivity with molecular dynamics and mm-pbsa binding free energy calculations. | Q54589320 | ||
Molecular dynamics simulation, free energy calculation and structure-based 3D-QSAR studies of B-RAF kinase inhibitors. | Q54611396 | ||
Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems | Q56750591 | ||
Binding affinities in the SAMPL3 trypsin and host–guest blind tests estimated with the MM/PBSA and LIE methods | Q56975687 | ||
The normal-mode entropy in the MM/GBSA method: effect of system truncation, buffer region, and dielectric constant | Q57126949 | ||
Aqueous Solvation Free Energies of Ions and Ion−Water Clusters Based on an Accurate Value for the Absolute Aqueous Solvation Free Energy of the Proton | Q57250536 | ||
Pairwise solute descreening of solute charges from a dielectric medium | Q57250689 | ||
Parametrized Models of Aqueous Free Energies of Solvation Based on Pairwise Descreening of Solute Atomic Charges from a Dielectric Medium | Q57402396 | ||
Understanding microscopic binding of macrophage migration inhibitory factor with phenolic hydrazones by molecular docking, molecular dynamics simulations and free energy calculations | Q58195329 | ||
Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation | Q29617869 | ||
Characterization of domain-peptide interaction interface: prediction of SH3 domain-mediated protein-protein interaction network in yeast by generic structure-based models | Q30010144 | ||
Proteome-wide detection of Abl1 SH3-binding peptides by integrating computational prediction and peptide microarray | Q30010218 | ||
Characterization of domain-peptide interaction interface: a generic structure-based model to decipher the binding specificity of SH3 domains | Q30157459 | ||
An analysis of the interactions between the Sem-5 SH3 domain and its ligands using molecular dynamics, free energy calculations, and sequence analysis. | Q30168058 | ||
Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. | Q30333153 | ||
The ASTRAL Compendium in 2004 | Q30336507 | ||
The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling | Q30406909 | ||
Binding of a diverse set of ligands to avidin and streptavidin: an accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models | Q31446320 | ||
Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance | Q33667350 | ||
Computational alanine scanning of the 1:1 human growth hormone-receptor complex | Q34120440 | ||
The experimental uncertainty of heterogeneous public K(i) data. | Q34285419 | ||
The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures | Q34323005 | ||
The PDBbind database: methodologies and updates | Q34424778 | ||
MM/GBSA binding energy prediction on the PDBbind data set: successes, failures, and directions for further improvement. | Q34523014 | ||
Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations | Q34531578 | ||
Can MM-PBSA calculations predict the specificities of protein kinase inhibitors? | Q34573536 | ||
Prediction of peptides binding to the PKA RIIalpha subunit using a hierarchical strategy | Q35051913 | ||
Predicting drug resistance of the HIV-1 protease using molecular interaction energy components | Q35534782 | ||
CHARMM-GUI Ligand Binder for absolute binding free energy calculations and its application | Q36569443 | ||
Accurate calculation of mutational effects on the thermodynamics of inhibitor binding to p38α MAP kinase: a combined computational and experimental study | Q37063817 | ||
Perspective on Free-Energy Perturbation Calculations for Chemical Equilibria | Q37426275 | ||
Free energy via molecular simulation: applications to chemical and biomolecular systems | Q38648060 | ||
Molecular dynamic investigations of the mutational effects on structural characteristics and tunnel geometry in CYP17A1. | Q39318890 | ||
Accounting for ligand conformational restriction in calculations of protein-ligand binding affinities | Q39343604 | ||
Exploring the molecular mechanism of cross-resistance to HIV-1 integrase strand transfer inhibitors by molecular dynamics simulation and residue interaction network analysis | Q39505190 | ||
Explicit Ligand Hydration Shells Improve the Correlation between MM-PB/GBSA Binding Energies and Experimental Activities. | Q40303491 | ||
Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking | Q41921801 | ||
On the use of orientational restraints and symmetry corrections in alchemical free energy calculations | Q42106721 | ||
Molecular modeling study on the resistance mechanism of HCV NS3/4A serine protease mutants R155K, A156V and D168A to TMC435. | Q43048011 | ||
Molecular basis of the interaction for an essential subunit PA-PB1 in influenza virus RNA polymerase: insights from molecular dynamics simulation and free energy calculation | Q43250372 | ||
Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA. | Q43678172 | ||
Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies | Q44290423 | ||
How well does Poisson-Boltzmann implicit solvent agree with explicit solvent? A quantitative analysis | Q44474068 | ||
P433 | issue | 31 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 11 | |
P304 | page(s) | 16719-16729 | |
P577 | publication date | 2014-08-01 | |
P1433 | published in | Physical Chemistry Chemical Physics | Q3018671 |
P1476 | title | Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. | |
P478 | volume | 16 |
Q51070839 | A fragment-based docking simulation for investigating peptide-protein bindings. |
Q47400790 | A theoretical insight into selectivity of inhibitors toward two domains of bromodomain-containing protein 4 using molecular dynamics simulations. |
Q38997273 | A theoretical study on the molecular determinants of the affibody protein Z(Aβ3) bound to an amyloid β peptide. |
Q94211057 | ACID: a free tool for drug repurposing using consensus inverse docking strategy |
Q92236968 | Abietic acid suppresses non-small-cell lung cancer cell growth via blocking IKKβ/NF-κB signaling |
Q57492347 | Adaptive Steered Molecular Dynamics Combined With Protein Structure Networks Revealing the Mechanism of Y68I/G109P Mutations That Enhance the Catalytic Activity of D-psicose 3-Epimerase From |
Q47139135 | Allosteric inhibitor remotely modulates the conformation of the orthestric pockets in mutant IDH2/R140Q. |
Q40536980 | Allosteric mechanism of cyclopropylindolobenzazepine inhibitors for HCV NS5B RdRp via dynamic correlation network analysis |
Q55385594 | An Efficient Implementation of the Nwat-MMGBSA Method to Rescore Docking Results in Medium-Throughput Virtual Screenings. |
Q30238530 | Applications of computer-aided approaches in the development of hepatitis C antiviral agents |
Q38620756 | Aromatic interactions at the ligand-protein interface: Implications for the development of docking scoring functions |
Q39959298 | Assessing the ligand selectivity of sphingosine kinases using molecular dynamics and MM-PBSA binding free energy calculations |
Q54323649 | Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring. |
Q57120322 | Assessing the performance of MM/PBSA and MM/GBSA methods. 8. Predicting binding free energies and poses of protein-RNA complexes |
Q39574481 | Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein-protein binding free energies and re-rank binding poses generated by protein-protein docking |
Q54294766 | Atomistic insights into the lung cancer-associated L755P mutation in HER2 resistance to lapatinib: a molecular dynamics study. |
Q39692774 | BiPPred: Combined sequence- and structure-based prediction of peptide binding to the Hsp70 chaperone BiP. |
Q38291300 | Binding free energy calculations on E-selectin complexes with sLex oligosaccharide analogs |
Q92566456 | Binding interactions of epididymal protease inhibitor and semenogelin-1: a homology modeling, docking and molecular dynamics simulation study |
Q40206445 | Binding mechanisms of 1,4-dihydropyridine derivatives to L-type calcium channel Cav1.2: a molecular modeling study |
Q47770494 | Binding modes and pathway of RHPS4 to human telomeric G-quadruplex and duplex DNA probed by all-atom molecular dynamics simulations with explicit solvent |
Q47348359 | Binding modes of Bcl-2 homology 3 (BH3) peptides with anti-apoptotic protein A1 and redesign of peptide inhibitors: a computational study. |
Q49021624 | Binding of ACE-inhibitors to in vitro and patient-derived amyloid-β fibril models. |
Q59802679 | Binding of Telomestatin, TMPyP4, BSU6037, and BRACO19 to a Telomeric G-Quadruplex–Duplex Hybrid Probed by All-Atom Molecular Dynamics Simulations with Explicit Solvent |
Q47735225 | Binding of anticancer drug daunomycin to a TGGGGT G-quadruplex DNA probed by all-atom molecular dynamics simulations: additional pure groove binding mode and implications on designing more selective G-quadruplex ligands |
Q37363075 | Binding-affinity predictions of HSP90 in the D3R Grand Challenge 2015 with docking, MM/GBSA, QM/MM, and free-energy simulations |
Q38994734 | Can We Rely on Computational Predictions To Correctly Identify Ligand Binding Sites on Novel Protein Drug Targets? Assessment of Binding Site Prediction Methods and a Protocol for Validation of Predicted Binding Sites |
Q90692094 | Carbon Nanoparticles Inhibit the Aggregation of Prion Protein as Revealed by Experiments and Atomistic Simulations |
Q42364944 | Cas9-catalyzed DNA Cleavage Generates Staggered Ends: Evidence from Molecular Dynamics Simulations |
Q48245176 | Cation-π interactions in CREBBP bromodomain inhibition: an electrostatic model for small-molecule binding affinity and selectivity |
Q38988546 | Characterization of the Interaction between Gallic Acid and Lysozyme by Molecular Dynamics Simulation and Optical Spectroscopy |
Q91111834 | Communication between the Ligand-Binding Pocket and the Activation Function-2 Domain of Androgen Receptor Revealed by Molecular Dynamics Simulations |
Q38935370 | Computational Approaches to the Chemical Equilibrium Constant in Protein-ligand Binding |
Q47362549 | Computational Modeling of the Hsp90 Interactions with Cochaperones and Small-Molecule Inhibitors |
Q93142938 | Computational Systems Pharmacology-Target Mapping for Fentanyl-Laced Cocaine Overdose |
Q39041742 | Computational identification of novel entry inhibitor scaffolds mimicking primary receptor CD4 of HIV-1 gp120. |
Q57289875 | Computational strategy for bound state structure prediction in structure-based virtual screening: a case study of protein tyrosine phosphatase receptor type O inhibitors |
Q40962998 | Computational study on the drug resistance mechanism of HCV NS3 protease to BMS-605339. |
Q40826753 | Computationally unraveling how ceritinib overcomes drug-resistance mutations in ALK-rearranged lung cancer |
Q36824248 | Constructing and Validating High-Performance MIEC-SVM Models in Virtual Screening for Kinases: A Better Way for Actives Discovery |
Q92489488 | DLIGAND2: an improved knowledge-based energy function for protein-ligand interactions using the distance-scaled, finite, ideal-gas reference state |
Q58756207 | Deciphering the Odorant Binding, Activation, and Discrimination Mechanism of Dhelobp21 from Dastarus Helophoroides |
Q59101223 | Defining the Specificity of Carbohydrate–Protein Interactions by Quantifying Functional Group Contributions |
Q58698253 | Discovery and Identification of Pyrazolopyramidine Analogs as Novel Potent Androgen Receptor Antagonists |
Q92923869 | Discrimination of Naturally-Occurring 2-Arylbenzofurans as Cyclooxygenase-2 Inhibitors: Insights into the Binding Mode and Enzymatic Inhibitory Activity |
Q39025566 | Dissecting the Cytochrome P450 1A2- and 3A4-Mediated Metabolism of Aflatoxin B1 in Ligand and Protein Contributions |
Q52316233 | Dissecting the Innate Immune Recognition of Opioid Inactive Isomer (+)-Naltrexone Derived Toll-like Receptor 4 (TLR4) Antagonists. |
Q89623468 | Dynamics Insights Into the Gain of Flexibility by Helix-12 in ESR1 as a Mechanism of Resistance to Drugs in Breast Cancer Cell Lines |
Q51075716 | Effect of electrostatic polarization and bridging water on CDK2-ligand binding affinities calculated using a highly efficient interaction entropy method. |
Q92581710 | Effect of mutations on binding of ligands to guanine riboswitch probed by free energy perturbation and molecular dynamics simulations |
Q37622781 | Effect of polarization on HIV-1protease and fluoro-substituted inhibitors binding energies by large scale molecular dynamics simulations |
Q48022145 | Effect of sampling on BACE-1 ligands binding free energy predictions via MM-PBSA calculations |
Q36061556 | Effect of single point mutations in a form of systemic amyloidosis. |
Q57492456 | Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and Challenges |
Q36625958 | Evaluating thermodynamic integration performance of the new amber molecular dynamics package and assess potential halogen bonds of enoyl-ACP reductase (FabI) benzimidazole inhibitors |
Q91668311 | Experimentally guided computational antibody affinity maturation with de novo docking, modelling and rational design |
Q64115443 | Exploration of Catalytic Selectivity for Aminotransferase (BtrR) Based on Multiple Molecular Dynamics Simulations |
Q55302171 | Exploring PAZ/3'-overhang interaction to improve siRNA specificity. A combined experimental and modeling study. |
Q40685694 | Exploring resistance mechanisms of HCV NS3/4A protease mutations to MK5172: insight from molecular dynamics simulations and free energy calculations |
Q39630932 | Exploring stereochemical specificity of phosphotriesterase by MM-PBSA and MM-GBSA calculation and steered molecular dynamics simulation |
Q55229082 | Exploring the Interaction Mechanism Between Cyclopeptide DC3 and Androgen Receptor Using Molecular Dynamics Simulations and Free Energy Calculations. |
Q57167603 | Exploring the Reasons for Decrease in Binding Affinity of HIV-2 Against HIV-1 Protease Complex Using Interaction Entropy Under Polarized Force Field |
Q41667510 | Exploring the binding mechanisms of MIF to CXCR2 using theoretical approaches |
Q47412506 | Exploring the influence of hyperthermophilic protein Ssh10b on the stability and conformation of RNA by molecular dynamics simulation. |
Q51288369 | Exploring the mechanism how AF9 recognizes and binds H3K9ac by molecular dynamics simulations and free energy calculations. |
Q92113799 | Fast Identification of Possible Drug Treatment of Coronavirus Disease -19 (COVID-19) Through Computational Drug Repurposing Study |
Q47272039 | Flavonoids as potent allosteric inhibitors of protein tyrosine phosphatase 1B: molecular dynamics simulation and free energy calculation. |
Q93200393 | Gibbs Free Energy Calculation of Mutation in PncA and RpsA Associated With Pyrazinamide Resistance |
Q93016827 | Glucose-6-Phosphate Upregulates Txnip Expression by Interacting With MondoA |
Q47250694 | HawkRank: a new scoring function for protein-protein docking based on weighted energy terms. |
Q89834325 | How Different Substitution Positions of F, Cl Atoms in Benzene Ring of 5-Methylpyrimidine Pyridine Derivatives Affect the Inhibition Ability of EGFRL858R/T790M/C797S Inhibitors: A Molecular Dynamics Simulation Study |
Q41490661 | How Does the L884P Mutation Confer Resistance to Type-II Inhibitors of JAK2 Kinase: A Comprehensive Molecular Modeling Study. |
Q92002890 | Identification of NUDT5 Inhibitors From Approved Drugs |
Q92533784 | Identification of an Activating Mutation in the Extracellular Domain of HER2 Conferring Resistance to Pertuzumab |
Q64063487 | Importance of Incorporating Protein Flexibility in Molecule Modeling: A Theoretical Study on Type I NIK Inhibitors |
Q41490277 | Importance of protein flexibility in ranking inhibitor affinities: modeling the binding mechanisms of piperidine carboxamides as Type I1/2 ALK inhibitors |
Q47225930 | Importance of protein flexibility on molecular recognition: modeling binding mechanisms of aminopyrazine inhibitors to Nek2. |
Q92619786 | In Silico Identification of Novel Aromatic Compounds as Potential HIV-1 Entry Inhibitors Mimicking Cellular Receptor CD4 |
Q64272548 | Increased gene copy number of worsens sepsis by inducing endothelial pyroptosis |
Q92255598 | Indole-Containing Phytoalexin-Based Bioisosteres as Antifungals: In Vitro and In Silico Evaluation against Fusarium oxysporum |
Q35871478 | Influence of Chirality of Crizotinib on Its MTH1 Protein Inhibitory Activity: Insight from Molecular Dynamics Simulations and Binding Free Energy Calculations |
Q48191027 | Influence of EGCG on α-synuclein (αS) aggregation and identification of their possible binding mode: A computational study using molecular dynamics simulation |
Q61806969 | Insight Into the Binding Mechanism of p53/pDIQ-MDMX/MDM2 With the Interaction Entropy Method |
Q89738273 | Insight into Ginkgo biloba L. Extract on the Improved Spatial Learning and Memory by Chemogenomics Knowledgebase, Molecular Docking, Molecular Dynamics Simulation, and Bioassay Validations |
Q55220361 | Insight into the substrate specificity change caused by the Y227H mutation of α-glucosidase III from the European honeybee (Apis mellifera) through molecular dynamics simulations. |
Q50797726 | Interaction mechanism exploration of R-bicalutamide/S-1 with WT/W741L AR using molecular dynamics simulations. |
Q98196770 | Ligand-bound glutamine binding protein assumes multiple metastable binding sites with different binding affinities |
Q58710194 | Molecular Dynamics Exploration of Selectivity of Dual Inhibitors 5M7, 65X, and 65Z toward Fatty Acid Binding Proteins 4 and 5 |
Q51144561 | Molecular Dynamics Studies on the Enzalutamide Resistance Mechanisms Induced by Androgen Receptor Mutations. |
Q48043854 | Molecular basis of P450 OleTJE: an investigation of substrate binding mechanism and major pathways. |
Q40374329 | Molecular dynamics and MM/GBSA-integrated protocol probing the correlation between biological activities and binding free energies of HIV-1 TAR RNA inhibitors. |
Q38691180 | Molecular dynamics investigations of membrane-bound CYP2C19 polymorphisms reveal distinct mechanisms for peripheral variants by long-range effects on the enzymatic activity. |
Q38853146 | Molecular dynamics investigations of regioselectivity of anionic/aromatic substrates by a family of enzymes: a case study of diclofenac binding in CYP2C isoforms |
Q47662738 | Molecular dynamics simulation, binding free energy calculation and unbinding pathway analysis on selectivity difference between FKBP51 and FKBP52: Insight into the molecular mechanism of isoform selectivity. |
Q51325445 | Molecular mechanism of R-bicalutamide switching from androgen receptor antagonist to agonist induced by amino acid mutations using molecular dynamics simulations and free energy calculation. |
Q40935601 | Molecular modeling study on the drug resistance mechanism of NS5B polymerase to TMC647055. |
Q58699620 | Phosphorylation promotes binding affinity of Rap-Raf complex by allosteric modulation of switch loop dynamics |
Q38764353 | Predicting binding modes of reversible peptide-based inhibitors of falcipain-2 consistent with structure-activity relationships. |
Q114061418 | Predicting the mutation effects of protein–ligand interactions via end-point binding free energy calculations: strategies and analyses |
Q59796192 | Prediction of GluN2B-CT/DAPK1 Interaction by Protein⁻Peptide Docking and Molecular Dynamics Simulation |
Q47902216 | Prediction of luciferase inhibitors by the high-performance MIEC-GBDT approach based on interaction energetic patterns |
Q64092663 | Probing the Behaviour of Cas1-Cas2 upon Protospacer Binding in CRISPR-Cas Systems using Molecular Dynamics Simulations |
Q59799911 | Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18 |
Q89208049 | Quantitative surface field analysis: learning causal models to predict ligand binding affinity and pose |
Q47713335 | Recent Developments and Applications of the MMPBSA Method |
Q33572781 | Revealing inhibition difference between PFI-2 enantiomers against SETD7 by molecular dynamics simulations, binding free energy calculations and unbinding pathway analysis |
Q35080674 | Revealing the favorable dissociation pathway of type II kinase inhibitors via enhanced sampling simulations and two-end-state calculations |
Q40513178 | Role of R292K mutation in influenza H7N9 neuraminidase toward oseltamivir susceptibility: MD and MM/PB(GB)SA study |
Q41674692 | Statistical Analysis on the Performance of Molecular Mechanics Poisson-Boltzmann Surface Area versus Absolute Binding Free Energy Calculations: Bromodomains as a Case Study |
Q92515232 | Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling |
Q38876079 | Structural identification of an HER2 receptor model binding pocket to optimize lead compounds: a combined experimental and computational approach |
Q91986503 | Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis |
Q53363967 | Target specific proteochemometric model development for BACE1 - protein flexibility and structural water are critical in virtual screening. |
Q35745162 | The Carboxy Terminus of the Ligand Peptide Determines the Stability of the MHC Class I Molecule H-2Kb: A Combined Molecular Dynamics and Experimental Study |
Q27012984 | The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities |
Q64987688 | The impact of interior dielectric constant and entropic change on HIV-1 complex binding free energy prediction. |
Q58119877 | The origin of specificity and insight into recognition between an aminoacyl carrier protein and its partner ligase |
Q40377857 | Theoretical studies on FGFR isoform selectivity of FGFR1/FGFR4 inhibitors by molecular dynamics simulations and free energy calculations |
Q48930138 | Theoretical studies on the selective mechanisms of GSK3β and CDK2 by molecular dynamics simulations and free energy calculations. |
Q47267118 | To probe interaction of morphine and IBNtxA with 7TM and 6TM variants of the human μ-opioid receptor using all-atom molecular dynamics simulations with an explicit membrane |
Q47129892 | Trypsin-Ligand binding affinities calculated using an effective interaction entropy method under polarized force field. |
Q35923779 | Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses |
Q47564438 | Unraveling the molecular mechanism of interactions of the Rho GTPases Cdc42 and Rac1 with the scaffolding protein IQGAP2. |
Q97086757 | Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors |
Search more.